Bristol-Myers Squibb CompanyBMYNYSE
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
6.25%
↓ 40% below average
Average (9y)
10.42%
Historical baseline
Range
High:60.65%
Low:-2.17%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 6.25% |
| 2023 | -2.17% |
| 2022 | -1.28% |
| 2021 | -0.25% |
| 2020 | 60.65% |
| 2019 | 15.94% |
| 2018 | 3.26% |
| 2017 | 12.80% |
| 2016 | 9.12% |
| 2015 | -0.15% |